Showing results (1991-2000 of 3,477) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|August 3, 1999
Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteersL M Cass, C Efthymiopoulos, A ByeClinical Pharmacokinetics|August 3, 1999
Effect of renal impairment on the pharmacokinetics of intravenous zanamivirL M Cass, C Efthymiopoulos, J Marsh, et al.Clinical Pharmacokinetics|August 3, 1999
Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteersL M Cass, J Brown, M Pickford, et al.Clinical Pharmacokinetics|April 5, 2000
Is there a role for therapeutic drug monitoring of new anticonvulsants?E PeruccaClinical Pharmacokinetics|April 5, 2000
Age-related changes in protein binding of drugs: implications for therapyM K Grandison, F D BoudinotClinical Pharmacokinetics|May 10, 2000
Metabolism and pharmacokinetics of oxazaphosphorinesA V Boddy, S M YuleClinical Pharmacokinetics|May 10, 2000
A concept for pharmacokinetic-pharmacodynamic dosage adjustment in renal impairment: the case of aminoglycosidesD Czock, M Giehl, F KellerClinical Pharmacokinetics|January 11, 2000
Cytochrome P450 3A: ontogeny and drug dispositionS N de Wildt, G L Kearns, J S Leeder, et al.Clinical Pharmacokinetics|December 20, 1999
Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisationA Sánchez-Navarro, M M Sánchez RecioClinical Pharmacokinetics|December 20, 1999
Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerationsS Nishino, E MignotPageof 348